biospecimen__admin__batch_number	405.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	FE2352EB-1B40-4BFB-ADA2-92D9505C7B54
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-WX-AA47-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-WX-AA47-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-WX-AA47-01A
biospecimen__bio__biospecimen_barcode_bottom	0167788029
biospecimen__bio__day_of_creation	08
biospecimen__bio__day_of_shipment	30
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	03
biospecimen__bio__month_of_shipment	04
biospecimen__bio__pathology_report_file_name	TCGA-WX-AA47.473868C8-CFDF-42E6-B6DC-48A737697D07.pdf
biospecimen__bio__plate_column	3
biospecimen__bio__plate_id	A39D
biospecimen__bio__plate_row	A
biospecimen__bio__quantity	2.21
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	13.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-WX-AA47
biospecimen__shared__patient_id	AA47
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	D7108BE0-6507-4453-87C9-8AD5C1516CE7
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	2.8
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.2
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.5
clinical__chol_lihc_shared__creatinine_upper_limit	1.2
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.6
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	1
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	No History of Primary Risk Factors
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.8
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	350
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	Macro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	33
clinical__clin_shared__day_of_form_completion	10
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	2
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__measure_of_response	Clinical Progressive Disease
clinical__clin_shared__month_of_form_completion	6
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	423
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	YES
clinical__clin_shared__radiation_therapy	YES
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2012
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__days_to_new_tumor_event_after_initial_treatment	103
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	YES
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__rad__anatomic_treatment_site	Regional site
clinical__rad__bcr_radiation_barcode	TCGA-WX-AA47-R60470
clinical__rad__bcr_radiation_uuid	7C0B3A36-0D89-4466-BB17-34D7001A5DF9
clinical__rad__days_to_radiation_therapy_end	340
clinical__rad__days_to_radiation_therapy_start	156
clinical__rad__radiation_treatment_ongoing	NO
clinical__rad__radiation_type	Internal
clinical__rx__bcr_drug_barcode	TCGA-WX-AA47-D60468
clinical__rx__bcr_drug_uuid	922F00F2-DA7A-4866-B953-CE6B32C5B780
clinical__rx__days_to_drug_therapy_end	493
clinical__rx__days_to_drug_therapy_start	331
clinical__rx__drug_name	Sorafenib
clinical__rx__therapy_ongoing	NO
clinical__rx__therapy_type	Chemotherapy
clinical__rx__tx_on_clinical_trial	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	MX
clinical__shared_stage__pathologic_n	NX
clinical__shared_stage__pathologic_t	T3a
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	676d126f-b0c7-4c79-b4b6-852207b31437
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-WX-AA47-01A-11R-A39D-07
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	48a3e690-61b6-4eab-8eea-08b732357651,11a8bdd7-7deb-4438-94db-c2111cfe276e,f43f1c16-0aa1-4d07-af31-fb82a5c32636
gdc__analysis__workflow_link	https://github.com/NCI-GDC/htseq-cwl
gdc__analysis__workflow_type	HTSeq - Counts,HTSeq - FPKM-UQ,HTSeq - FPKM
gdc__analysis__workflow_version	v1
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	8d7954d2-d4c2-4c25-b23a-35cd17092529
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	39e147c9-2acb-4ba8-a991-e43e1719b2d8
gdc__center__center_id	ee7a85b3-8177-5d60-a10c-51180eb9009c
gdc__center__center_type	CGCC
gdc__center__code	07
gdc__center__name	University of North Carolina
gdc__center__namespace	unc.edu
gdc__center__short_name	UNC
gdc__created_datetime	2016-05-29T10:13:52.638889-05:00,2016-05-29T10:13:52.847107-05:00,2016-05-29T10:13:53.049014-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	Gene Expression Quantification
gdc__demographic__demographic_id	4947348d-9bac-5121-b4a8-ae52df695be9
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	female
gdc__demographic__race	white
gdc__demographic__year_of_birth	1979
gdc__demographic__year_of_death	2013
gdc__diagnoses__age_at_diagnosis	12056
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-12056.0
gdc__diagnoses__days_to_death	556.0
gdc__diagnoses__diagnosis_id	1c6d0c3a-4720-5c3c-980b-5474526dd233
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiia
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	RNA-Seq
gdc__exposures__bmi	22.321428571428573
gdc__exposures__exposure_id	6fc0da8c-7119-5275-8061-70c1b33891b2
gdc__exposures__height	168.0
gdc__exposures__weight	63.0
gdc__file_id	1fa396b8-93de-44fb-a636-8f4790658cdc,d1c3351e-a1e3-49ee-836d-5dfb5a9fce3f,5c1550cb-6335-4433-b3cf-2c36e430d093
gdc__file_name	004c60cf-c08e-49df-b4ce-baca41e11250.htseq.counts.gz,004c60cf-c08e-49df-b4ce-baca41e11250.FPKM-UQ.txt.gz,004c60cf-c08e-49df-b4ce-baca41e11250.FPKM.txt.gz
gdc__file_size	240086,472085,470032
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	RNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	fc6cc936a5942ee3f49b45ffcc4d3abd,6c8248bf342499af2c01814c676bc494,7507f0112651862cef73a0f6d0d1b116
gdc__portions__is_ffpe	false
gdc__portions__portion_id	994fc34c-b844-467b-9b49-a320365032ce
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	626
gdc__samples__initial_weight	60.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	473868C8-CFDF-42E6-B6DC-48A737697D07
gdc__samples__sample_id	45f1a40f-b2c2-45a2-aec8-954945857c31
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	0.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	5.0
gdc__slides__percent_tumor_cells	95.0
gdc__slides__percent_tumor_nuclei	95.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	fc4fc9f0-2663-4d31-a1ba-0b1cbef0ca0d
gdc__submitter_id	004c60cf-c08e-49df-b4ce-baca41e11250_count,004c60cf-c08e-49df-b4ce-baca41e11250_uqfpkm,004c60cf-c08e-49df-b4ce-baca41e11250_fpkm
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	WX
gdc__tissue_source_site__name	Yale University
gdc__tissue_source_site__tissue_source_site_id	39c0854e-a35b-56ba-ae48-3d0f45b5c305
gdc__treatments__treatment_id	902caf48-8153-5066-8055-a347dbc45e78
gdc__type	gene_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T08:07:46.336+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/676d126f-b0c7-4c79-b4b6-852207b31437-geq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/gene_expression_quantification/676d126f-b0c7-4c79-b4b6-852207b31437-geq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	4988757
manually_curated__local_md5	8d0bcfb2f72daa57323d7ae463ca9358
manually_curated__opengdc_download_date	2018-10-15T16:29:16.000661+02:00
manually_curated__opengdc_file_md5	008aaa96b0d5eaca05dca58bd62aee5c
manually_curated__opengdc_file_size	1593602
manually_curated__opengdc_id	676d126f-b0c7-4c79-b4b6-852207b31437-geq
manually_curated__origin_file_size	4988757
manually_curated__origin_last_modified_date	Mon Oct 15 16:36:00 CEST 2018
manually_curated__origin_md5	8d0bcfb2f72daa57323d7ae463ca9358
manually_curated__tissue_status	tumoral
num	60483
